Akèy › Tit travay › Staff Research Associate
Staff Research Associate: Salè H-1B
81 aplikasyon kondisyon travay te itilize tit travay Staff Research Associate. Salè baz medyàn ofri $68,328; mwatye mitan $60,875–$81,828.
Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| University of California, Los Angeles | 32 | $65,124 |
| University of California, Berkeley | 16 | $71,602 |
| University of California, Davis | 8 | $76,788 |
| University of Oklahoma Health Sciences Center | 7 | $57,500 |
| Arc Research Institute | 6 | $107,000 |
| University of California at Santa Barbara | 4 | $69,366 |
| University of California, Irvine | 2 | $69,262 |
| University of California, Riverside | 2 | $65,778 |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 2 | $69,661 |
| University of California, San Diego | 1 | $65,545 |
| University of California, San Francisco | 1 | $62,442 |
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $60,400 |
| Nivo II (kalifye) | $71,412 |
| Nivo III (eksperyans) | $104,500 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 15 | $66,791 |
| FY2024 | 22 | $61,572 |
| FY2025 | 21 | $75,950 |
| FY2026 | 19 | $80,927 |
Vil yo
- Los Angeles, CA32
- Berkeley, CA16
- Davis, CA7
- Oklahoma City, OK7
- Palo Alto, CA6
- Santa Barbara, CA4
- Parlier, CA3
- Irvine, CA2
- Torrance, CA2
- La Jolla, CA1
- San Francisco, CA1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).